BDA 1.06% 46.5¢ bod australia limited

According to a clinician interviewed by the Australian Journal...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,096 Posts.
    lightbulb Created with Sketch. 267
    According to a clinician interviewed by the Australian Journal of Pharmacy, tackling the problem of addiction to codeine-based painkillers shall see them replaced by cannabis based products (once the Special Access Scheme Category B starts to kick in):

    “There’s actually a lot of research suggesting that marijuana can be a really good gateway out of opioid dependency,” he adds. “It has some benefits for pain management and is a lot safer, magnitudes safer, than opioids.
    “So it’s something that people could definitely transition to, but it’s an atypical pain reliever so not as accessible.”


    https://ajp.com.au/news/booze-risk-pain-sufferers/
    Last edited by aburbe: 12/02/18
 
watchlist Created with Sketch. Add BDA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.